Your browser doesn't support javascript.
loading
Impact of a multidisciplinary antimicrobial stewardship program on antibiotic utilization and clinical outcomes at a tertiary hospital in Saudi Arabia: a quasi-experimental study.
Sarkhi, Khadijah A; Eljaaly, Khalid; Kaki, Reham; Bahamdan, Rahaf; Alghamdi, Sultan A; Baharith, Mohammed O; Thabit, Abrar K.
Afiliação
  • Sarkhi KA; Department of Pharmaceutical Care Services, King Fahad Armed Forces Hospital, Jeddah, Saudi Arabia.
  • Eljaaly K; Department of Pharmaceutical Care Services, King Abdulaziz University Hospital, Jeddah, Saudi Arabia.
  • Kaki R; Department of Pharmacy Practice, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia.
  • Bahamdan R; Department of Medicine, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia.
  • Alghamdi SA; Department of Infectious Disease and Infection Control and Environmental Health, King Abdulaziz University Hospital, Jeddah, Saudi Arabia.
  • Baharith MO; Department of Pharmaceutical Care Services, King Abdulaziz University Hospital, Jeddah, Saudi Arabia.
  • Thabit AK; Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia.
Expert Rev Anti Infect Ther ; 22(1-3): 115-120, 2024.
Article em En | MEDLINE | ID: mdl-37974376
ABSTRACT

BACKGROUND:

This study aims to assess the impact of a multidisciplinary antimicrobial stewardship program (ASP) intervention on various metrics.

METHODS:

A quasi-experimental study was performed on non-ICU patients for whom a restricted antibiotic was ordered. In September 2020, a prospective audit and feedback was implemented involving infectious disease clinical pharmacists, utilization of electronic resources, and improved documentation. Outcomes included defined daily dose and days of therapy per 100-patient days (DDD/100PD and DOT/100PD) and patient clinical outcomes.

RESULTS:

402 episodes were evaluated for 167 and 190 unique patients in the pre- and post-intervention phases, respectively. DDD/100PD and DOT/100PD were lower in the post-phase than in the pre-phase (1.75 vs. 2.54 and 16.13 vs. 44.93). Antibiotic de-escalation and clinical cure rates were significantly higher in the post-phase than in the pre-phase (62% vs. 40.6% and 83.5% vs. 65.8%; P < 0.001 for both comparisons). Hospital and ICU stays were significantly shorter in the post-phase (14 vs. 22 and 3 vs. 9, respectively; P < 0.001 for both comparisons). In-hospital mortality and 30-day readmission rates were lower in the post-phase (13% vs. 20.8%; P = 0.037 and 20.5% vs. 33.8%; P = 0.003, respectively).

CONCLUSION:

The implemented multidisciplinary ASP intervention was associated with a significant improvement in antibiotic utilization and patient clinical outcomes.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Transmissíveis / Gestão de Antimicrobianos Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Transmissíveis / Gestão de Antimicrobianos Idioma: En Ano de publicação: 2024 Tipo de documento: Article